No Deviation or Variation in the use of proceeds raised through the Right Issue.
FUNDRAISE
▲ Positive Development
LOW RISK
📅 Filed on BSE: 26 May 2026, 08:31 PM IST · BSE ID: 45f55736-1f2e-4e79-95b1-09900c2a5c88
View Original BSE Filing (PDF)
💡
In Simple Terms
The company has confirmed that the money raised from its recent rights issue has been spent exactly as planned.
🤖 AI Summary
- Sadhana Nitro Chem confirms no deviation in using Rs. 263.53 Crores from Rights Issue.
- Funds raised on March 12, 2026, deployed across various corporate purposes.
- Statement reviewed by Audit Committee for quarter ended March 31, 2026.
- Monitoring agency Acuite Ratings and Research Limited involved in the process.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Amount raised
Rs. 263.53 Crores
Date of raising funds
March 12, 2026
Report filed for quarter ended
March 31, 2026
Fund Utilised
251.95 Crores
🏢 How This Affects the Company
Confirms adherence to capital allocation plans outlined during the Rights Issue, ensuring financial discipline and transparency in fund utilization.
Reduces risk associated with potential misuse of funds or a significant deviation from stated objectives, enhancing investor confidence in financial management.
👥 What This Means For Shareholders
✅
Action Required
No specific action is required from shareholders regarding this disclosure.
👤
Who Is Affected
All shareholders are informed about the transparent utilization of funds raised from the Rights Issue, impacting overall corporate governance perception.
🔍
Management Signal
This disclosure signals management's commitment to transparency and adherence to previously stated financial objectives.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Next quarter's filing for updated fund utilization status.
Future announcements on the specific deployment of remaining funds.
Monitoring agency reports for any subsequent reviews or findings.
LOW RISK
Disclosure confirms adherence to planned fund utilization from the Rights Issue.
💡 Investor Takeaway
Sadhana Nitro Chem confirms no deviation in the use of Rs. 263.53 Crores raised via Rights Issue for the quarter ended March 31, 2026. Total utilization stands at Rs. 251.95 Crores.
⚖️ Strengths & Concerns
✅ Positives
- Confirmation of no deviation in utilizing Rs. 263.53 Crores raised via Rights Issue.
- Funds utilized strictly according to original allocation, demonstrating financial control.
⚠️ Concerns
- Rs. 11.58 Crores of the total Rs. 263.53 Crores raised remains unutilized as of March 31, 2026.
- Significant allocation (Rs. 131.98 Crores) towards Inter-Corporate Deposit, indicating a focus on liquidity or short-term deployments.
📅 Company Track Record
Sadhana Nitro Chem Limited recently completed a Rights Issue in March 2026, listing 26,35,28,33,28 equity shares on BSE and NSE.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What is the total amount raised by Sadhana Nitro Chem through its Rights Issue?
Sadhana Nitro Chem Limited raised Rs. 263.53 Crores through its Rights Issue.
When was the Rights Issue fund raised by Sadhana Nitro Chem?
The funds were raised on March 12, 2026.
Has Sadhana Nitro Chem reported any deviation in the use of Rights Issue proceeds for the quarter ended March 31, 2026?
No, Sadhana Nitro Chem has confirmed there is no deviation or variation in the use of proceeds raised through the Rights Issue.
What was the total amount utilized from the Rights Issue funds as of March 31, 2026?
As of March 31, 2026, a total of Rs. 251.95 Crores has been utilized from the funds raised.
Who is the monitoring agency for Sadhana Nitro Chem's Rights Issue fund utilization?
Acuite Ratings and Research Limited is the applicable monitoring agency for the Rights Issue fund utilization.
Questions based on this BSE filing only. For information purposes.